Friday November 27 2009 | Biotechnology feed | All feeds
|
|
|
PDL BioPharma, Inc.http://www.pdl.com Protein Design Labs Incorporated, Freemont CA, United States of America. PDL is a leader in the development of humanized monoclonal antibodies for the prevention and treatment of a variety of disease conditions. PDL currently has antibodies under development for autoimmune Ticker - PDL BioPharma to Present at the 8th Annual JMP Securities Research Conference on May 18, 2009Tuesday 12th of May 2009 8:00BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
 Browse other news from this organisation: PDL BioPharma, Inc. Related Web-Links(If any, Generated Automatically)Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
